SGO 2025 | 30余项中国研究入选，SGO 2025中国成果全景扫描

SGO 2025

第56届美国妇科肿瘤学年会（SGO 2025）将于3月14-17日在西雅图举办。此次会议将汇聚全球顶尖学者、临床专家与科研团队，围绕妇科肿瘤的早期筛查、精准治疗、转化医学及患者管理等议题展开深入探讨，为推动学科发展与临床实践注入新动能。在SGO 2025这一国际舞台上，来自中国的研究团队将展示多项突破性研究成果。本文系统梳理了中国学者入选SGO 2025会议的报告，通过聚焦这些成果，我们期待以中国智慧为全球妇科肿瘤防治事业提供更多启示与解决方案。

Scientific Plenary

摘要ID：864114

英文标题：Cadonilimab plus lenvatinib in patients with advanced endometrial cancer: a multicenter, single-arm, phase II trial

讲者：蓝春燕 中山大学肿瘤防治中心

摘要ID：812874

英文标题：Sentinel Lymph Node Biopsy versus Pelvic Lymphadenectomy in Cervical Cancer: the PHENIX-I trial

讲者：刘继红 中山大学肿瘤防治中心

摘要ID：927707

英文标题：Comparing Efficacy and Safety of Biweekly Single-Dose Actinomycin D versus Multiday Methotrexate Therapy in Low-Risk Gestational Trophoblastic Neoplasia: A Prospective Multicentre Randomized Trial

讲者：蒋芳 北京协和医院

Focused Forum

摘要ID：852145

英文标题：Zimberelimab plus lenvatinib in patients with advanced cervical cancer who progressed after prior immune checkpoint inhibitors: a multicenter, single-arm, phase II trial

讲者：蓝春燕 中山大学肿瘤防治中心

摘要ID：873424

英文标题：Immunotherapy Rechallenge with Cadonilimab in Patients with Recurrent or Metastatic Cervical Cancer: A Retrospective Study

讲者：Lin Jie 福建省肿瘤医院

摘要ID：937243

英文标题：Biomarker-driven Targeted Therapy in Platinum-Resistant Ovarian Cancer (PROC): Results from the BRIGHT Trial

讲者：高庆蕾 华中科技大学同济医学院附属同济医院

摘要ID：838826

英文标题：(ENCORE) An open-label, prospective phase II study of cadonilimab in combination with neoadjuvant chemotherapy for patients diagnosed with advanced ovarian cancer (AK104-IIT-003)

讲者：唐洁 湖南省肿瘤医院

Featured Poster Session

摘要ID：823842

英文标题：AK104 combined with concurrent chemoradiotherapy for the treatment of locally advanced Cervical Cancer

讲者：蒋芳 北京协和医院

摘要ID：823525

英文标题：Neoadjuvant Chemotherapy Followed by Chemoradiation Plus Adjuvant Chemotherapy for Locally Advanced Cervical Cancer: A Real-World Study with 10 Years Experience

讲者：唐洁 湖南省肿瘤医院

摘要ID：859742

英文标题：Pamiparib in combination with surufatinib in patients with platinum-resistant ovarian cancer who received prior PARP inhibitors: a multicenter, single-arm, phase Ib/II trial (POST-PARPi Trial)

讲者：蓝春燕 中山大学肿瘤防治中心

Poster Tour

摘要ID：823980

英文标题：Enlonstobart (SG001) plus platinum-based chemotherapy ± bevacizumab for first-line treatment of PD-L1 positive recurrent/metastatic cervical cancer: safety run-in results of the phase III randomized, double-blind trial

讲者：佐晶 中国医学科学院肿瘤医院

摘要ID：820986

英文标题：Efficacy and safety of carboplatin/paclitaxel combined tislelizumab for recurrent ovarian cancer progressing within 6-12 months after the last platinum line.

讲者：杨谢兰 云南省肿瘤医院

摘要ID：851273

英文标题：Cadonilimab combined with TP regimen-induced cisplatin concurrent radiotherapy for locally advanced cervical cancer: A Prospective, Single-Arm Phase II Clinical Trial

讲者：李铭仪 广州医科大学附属肿瘤医院

摘要ID：826744

英文标题：Fluzoparib plus apatinib maintenance in patients with platinum-sensitive recurrent ovarian cancer who had received first-line maintenance with a PARP inhibitor (FLASH): A single-arm exploratory trial

讲者：王金华 江苏省肿瘤医院

摘要ID：826959

英文标题：The safety and efficacy of cadonilimab in advanced, recurrent, or metastatic cervical cancer: A multicenter, prospective, real-world study

讲者：Xu Yuanyuan 河南省肿瘤医院

Surgical Films:

Virtual Display on the App

摘要ID：872539

英文标题：Minimally invasive total vaginectomy utilizing robotic-assisted minimally invasive surgery and laparoscopic techniques for the management of malignant melanoma in the female reproductive system

讲者：何海新 福建省肿瘤医院

摘要ID：814185

英文标题：Resection of Ilio-inguinal Mass and Reconstruction with Artificial Vascular Graft in Vulvar Cancer Recurrence after Lymphadenectomy and Radiotherapy

讲者：涂画 中山大学肿瘤防治中心

Poster Session

摘要ID：819672

英文标题：Efbemalenograstim Alfa for Primary Prophylaxis of Chemotherapy-Induced Neutropenia In Patients With Ovarian and Cervical Cancer: A Single-Arm, Multicenter Clinical Trial

讲者：王丽梅 山东大学齐鲁医院

摘要ID：822135

英文标题：The immunohistochemical profile and clinicopathological features of Invasive stratified mucin-producing carcinoma.

讲者：王茹 山东省肿瘤医院

摘要ID：823810

英文标题：Long-term outcomes of local tumor destruction/excision not inferior to total hysterectomy for stage IA cervical cancer : A retrospective cohort study with propensity score matching analysis

讲者：徐沁 福建省肿瘤医院

摘要ID：837185

英文标题：Anlotinib + penpulimab plus chemo-less therapy in first-line treatment for persistent, recurrent, or metastatic cervical cancer: a single-arm, open-label phase a… study (ALTN-AK105-II-06)

讲者：徐沁 福建省肿瘤医院

摘要ID：819959

英文标题：A nomogram for predicting overall survival in patients with clear cell adenocarcinoma of the cervix: a population-based analysis

讲者：徐沁 福建省肿瘤医院

摘要ID：828451

英文标题：Anlotinib Enhances Immunotherapy Efficacy in PIK3CA-Mutant Cervical Cancer by Inhibiting RPS26-Mediated Activation of the PI3K/AKT Pathway

讲者：徐沁 福建省肿瘤医院

摘要ID：827266

英文标题：Exploring the Impact of Circulating Inflammatory Proteins on Cervical Cancer Lesion Progression: A Two-Sample Bidirectional Mendelian Randomization Study

讲者：徐沁 福建省肿瘤医院

摘要ID：869961

英文标题：Development and Validation of a Radiomics Nomogram for Metastasis Prediction in Neuroendocrine Carcinoma of the Cervix

讲者：余海娟 福建省肿瘤医院

摘要ID：841950

英文标题：Comparative Analysis of Laparoscopic versus Open Inguinal Lymphadenectomy in Vulvar Cancer Surgery from Single Cancer Center ten years data

讲者：张正茂 河北医科大学第四医院暨河北省肿瘤医院

摘要ID：854711

英文标题：Proteomics signatures of biofluid-derived small extracellular vesicles for diagnostic biomarkers and potential therapeutic targets of epithelial ovarian cancer.

讲者：郑小翠 上海交通大学医学院附属新华医院

摘要ID：831183

英文标题：ALTER-GO-010: A multicenter, single-arm, phase 2 study of anlotinib combined with carboplatin plus paclitaxel and maintenance anlotinib as front-line treatment for newly diagnosed advanced ovarian cancer

讲者：程文俊 江苏省人民医院

摘要ID：865356

英文标题：Laparoscopic Pelvic Lymph Node Dissection Plus Open Abdominal Radical hysterectomy

讲者：林洁 福建省肿瘤医院

摘要ID：827945

英文标题：A novel deep learning model for automatic segmentation in cervical cancer brachytherapy

讲者：徐沁 福建省肿瘤医院

摘要ID：832908

英文标题：Comparison of long-term clinical outcomes between patients with and without neoadjuvant therapy before surgery in stage IB2-IIB cervical cancer: a propensity score-matched study

讲者：徐沁 福建省肿瘤医院

摘要ID：823645

英文标题：The impact of the COVID-19 pandemic on the diagnosis, treatment, and prognosis of ovarian cancer in the United States:A retrospective cohort study based on the SEER database

讲者：徐沁 福建省肿瘤医院

摘要ID：827261

英文标题：Dynamic Role of Circulating Immune Cells in the Progression of Cervical Malignant Lesion: A Two-sample Mendelian Randomization Study

讲者：徐沁 福建省肿瘤医院

摘要ID：834366

英文标题：Nituzumab plus Serplulimab combined with SBRT in recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial

讲者：徐沁 福建省肿瘤医院

摘要ID：827311

英文标题：Lipids, as fundamental components of cells, exert a substantial influence on diverse biological processes. Although significant, their precise impact on cervical cancer development remains largely uncertain.

讲者：徐沁 福建省肿瘤医院

编辑：Faline

审校：Faline

排版：Faline

执行：Squid

医脉通是专业的在线医生平台，“感知世界医学脉搏，助力中国临床决策”是平台的使命。医脉通旗下拥有「临床指南」「用药参考」「医学文献王」「医知源」「e研通」「e脉播」等系列产品，全面满足医学工作者临床决策、获取新知及提升科研效率等方面的需求。

本平台旨在为医疗卫生专业人士传递更多医学信息。本平台发布的内容，不能以任何方式取代专业的医疗指导，也不应被视为诊疗建议。如该等信息被用于了解医学信息以外的目的，本平台不承担相关责任。本平台对发布的内容，并不代表同意其描述和观点。若涉及版权问题，烦请权利人与我们联系，我们将尽快处理。